The RX is Uproxx Music’s stamp of approval for the best albums, songs, and music stories throughout the year. Inclusion in this category is the highest distinction we can bestow, and signals the most ...

Our study sifts through research reports issued by six top AShSs, which show average drops of 11.2% in share prices of target companies within three days of publication. Like them or loathe them, ...

Even after signing with Nuclear Blast, Conjurer remains underrated relative to their immense talent. It's been four years since the UK quartet blessed the underground with Mire, an incredible debut LP ...

Two Tempus executives, including serial entrepreneur and billionaire Eric Lefkofsky, are behind a new drug discovery company in Chicago that's looking to raise $40 million. The startup, called Pathos ...

Tempus AI Inc (NASDAQ:TEM) shares are surging Wednesday after the company announced a multi-year collaboration with AstraZeneca PLC (NASDAQ:AZN) and Pathos AI. What To Know: Tempus AI announced a ...